Frequency of CYP2C9 genotypes among Omani patients receiving warfarin and its correlation with warfarin dose

Musbah O. Tanira*, Mohammed K. Al-Mukhaini, Ali T. Al-Hinai, Khalid A. Al Balushi, Ikhlas S. Ahmed

*المؤلف المقابل لهذا العمل

نتاج البحث: المساهمة في مجلةArticleمراجعة النظراء

28 اقتباسات (Scopus)

ملخص

Objectives: This study was conducted to determine the frequency of CYP2C9 alleles in Omani patients receiving warfarin and to correlate genotyping data with warfarin dosage. The Omani population has Asian and African ethnicities. Methods: CYP2C9 genotypes were determined by the polymerase chain reaction restriction fragment length polymorphism method. Non-parametric Kruskal-Wallis test was used to compare groups of continuous data for significance differences. Results: Genotyping data showed that 12.7 and 5.8% of the samples were heterozygous for the CYP2C9*2 and CYP2C9*3 alleles, respectively. The CYP2C9*2 allele frequency was 0.074 in our population. It was 0.029 for CYP2C9*3. Conclusion: This is the first report on the presence of CYP2C9*2 allele homozygocity in any Asian or African population.

اللغة الأصليةEnglish
الصفحات (من إلى)32-37
عدد الصفحات6
دوريةCommunity Genetics
مستوى الصوت10
رقم الإصدار1
المعرِّفات الرقمية للأشياء
حالة النشرPublished - ديسمبر 2006

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700.2716???

بصمة

أدرس بدقة موضوعات البحث “Frequency of CYP2C9 genotypes among Omani patients receiving warfarin and its correlation with warfarin dose'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا